MNPR short interest
Monopar Therapeutics Inc. · Healthcare · Biotechnology · settlement date 2026-09-30
| Shares short | 1,086,279 |
|---|---|
| Change vs prior report | 242,053 (+28.7%) |
| Change over six months | -35.5% |
| Days to cover | 6.02 (sector: 3.78) |
| Average daily volume | 180,448 |
| Rank in Healthcare | #320 of 922 by days to cover |
MNPR short interest, last 12 months
| Settlement | Shares short | Change | Days to cover | Avg daily volume |
|---|---|---|---|---|
| 2026-09-30 | 1,086,279 | +28.7% | 6.02 | 180,448 |
| 2026-09-15 | 844,226 | -1.0% | 7.20 | 117,229 |
| 2026-08-31 | 852,425 | -3.9% | 4.54 | 187,890 |
| 2026-08-14 | 887,188 | -16.7% | 3.48 | 255,273 |
| 2026-07-31 | 1,065,108 | -21.7% | 3.40 | 312,928 |
| 2026-07-15 | 1,360,286 | -10.5% | 5.94 | 228,940 |
| 2026-06-30 | 1,519,701 | -2.5% | 8.61 | 176,453 |
| 2026-06-15 | 1,558,148 | -1.3% | 12.54 | 124,250 |
| 2026-05-29 | 1,579,320 | +0.6% | 8.53 | 185,104 |
| 2026-05-15 | 1,569,220 | -6.1% | 8.05 | 195,039 |
| 2026-04-30 | 1,670,599 | -3.1% | 10.60 | 157,641 |
| 2026-04-15 | 1,723,274 | +2.3% | 9.34 | 184,547 |
| 2026-03-31 | 1,684,127 | +1.9% | 7.98 | 210,936 |
| 2026-03-13 | 1,653,442 | +4.0% | 10.45 | 158,269 |
| 2026-02-27 | 1,590,237 | +5.6% | 10.83 | 146,869 |
| 2026-02-13 | 1,506,521 | +11.2% | 5.11 | 295,012 |
| 2026-01-30 | 1,355,318 | +5.9% | 4.26 | 317,940 |
| 2026-01-15 | 1,279,274 | +21.1% | 4.07 | 314,035 |
| 2025-12-31 | 1,056,017 | +28.3% | 3.11 | 339,735 |
| 2025-12-15 | 822,858 | +62.2% | 4.55 | 181,013 |
| 2025-11-28 | 507,439 | +36.7% | 4.04 | 125,650 |
| 2025-11-14 | 371,120 | +44.5% | 1.99 | 186,456 |
| 2025-10-31 | 256,778 | +58.6% | 2.58 | 99,716 |
| 2025-10-15 | 161,927 | +9.5% | 1.71 | 94,744 |
| 2025-09-30 | 147,870 | +0.7% | 1.76 | 84,207 |
import finzdata as yf
yf.Ticker("MNPR").short_interest # every report since 2017
yf.Client().short_interest(["MNPR"], start="2018-01-01")Healthcare short interest · MNPR price history · Who owns MNPR · All short interest